As of 2024-12-15, the EV/EBITDA ratio of Bausch Health Companies Inc (BHC.TO) is 11.08. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. BHC.TO's latest enterprise value is 33,670.62 mil CAD. BHC.TO's TTM EBITDA according to its financial statements is 3,038.00 mil CAD. Dividing these 2 quantities gives us the above BHC.TO EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative Enterprise Value.
| Range | Selected | |
| Trailing P/E multiples | 5.6x - 7.7x | 6.6x |
| Forward P/E multiples | 11.7x - 18.5x | 15.1x |
| Fair Price | (19.10) - 16.23 | (1.90) |
| Upside | -272.2% - 46.4% | -117.1% |
| Date | EV/EBITDA |
| 2024-12-12 | 7.78 |
| 2024-12-11 | 7.76 |
| 2024-12-10 | 7.85 |
| 2024-12-09 | 7.86 |
| 2024-12-06 | 7.82 |
| 2024-12-05 | 7.81 |
| 2024-12-04 | 7.82 |
| 2024-12-03 | 7.81 |
| 2024-12-02 | 7.78 |
| 2024-11-29 | 7.86 |
| 2024-11-28 | 7.85 |
| 2024-11-27 | 7.81 |
| 2024-11-26 | 7.79 |
| 2024-11-25 | 7.79 |
| 2024-11-22 | 7.79 |
| 2024-11-21 | 7.82 |
| 2024-11-20 | 7.82 |
| 2024-11-19 | 7.82 |
| 2024-11-18 | 7.84 |
| 2024-11-15 | 7.86 |
| 2024-11-14 | 7.89 |
| 2024-11-13 | 7.89 |
| 2024-11-12 | 7.93 |
| 2024-11-11 | 7.95 |
| 2024-11-08 | 7.95 |
| 2024-11-07 | 7.95 |
| 2024-11-06 | 7.97 |
| 2024-11-05 | 7.98 |
| 2024-11-04 | 7.94 |
| 2024-11-01 | 8.00 |
| 2024-10-31 | 7.93 |
| 2024-10-30 | 7.81 |
| 2024-10-29 | 7.81 |
| 2024-10-28 | 7.81 |
| 2024-10-25 | 7.79 |
| 2024-10-24 | 7.80 |
| 2024-10-23 | 7.79 |
| 2024-10-22 | 7.80 |
| 2024-10-21 | 7.80 |
| 2024-10-18 | 7.80 |
| 2024-10-17 | 7.82 |
| 2024-10-16 | 7.83 |
| 2024-10-15 | 7.83 |
| 2024-10-11 | 7.77 |
| 2024-10-10 | 7.79 |
| 2024-10-09 | 7.77 |
| 2024-10-08 | 7.78 |
| 2024-10-07 | 7.79 |
| 2024-10-04 | 7.80 |
| 2024-10-03 | 7.80 |